Valtrex (Valacyclovir) is NOT Available in an Intravenous Formulation
Valtrex (valacyclovir) is only available as an oral tablet and has no intravenous (IV) formulation. 1 The FDA-approved drug label explicitly states that "VALTREX tablets are for oral administration" and describes valacyclovir as a prodrug that is rapidly converted to acyclovir after oral absorption through first-pass intestinal and hepatic metabolism 1.
Why This Matters Clinically
When severe herpes virus infections require intravenous therapy, you must use IV acyclovir, not valacyclovir. The guidelines are clear on this distinction:
- For severe mucocutaneous HSV lesions: IV acyclovir is the treatment of choice, not valacyclovir 2
- For HSV encephalitis: IV acyclovir 10 mg/kg every 8 hours for 14-21 days is required 3
- For disseminated HSV, pneumonitis, hepatitis, or CNS complications: IV acyclovir 5-10 mg/kg every 8 hours is indicated 4
The Oral-to-IV Relationship
Valacyclovir is the L-valyl ester prodrug of acyclovir, designed specifically to improve oral bioavailability. After oral administration, valacyclovir achieves 54.5% bioavailability of acyclovir—approximately 3-5 times better than oral acyclovir itself 1. This is why valacyclovir exists: to deliver therapeutic acyclovir levels orally that would otherwise require IV administration.
The pharmacokinetic comparison shows: A 1-gram oral dose of valacyclovir was compared directly to a 350-mg IV acyclovir dose to establish bioavailability 1. This demonstrates that oral valacyclovir can achieve plasma acyclovir concentrations comparable to IV acyclovir in certain clinical scenarios.
When Oral Valacyclovir Can Substitute for IV Acyclovir
Recent evidence suggests oral valacyclovir may be acceptable as an alternative to IV acyclovir in specific situations:
- Acute retinal necrosis: Oral valacyclovir showed clinical equivalence to IV acyclovir therapy with no difference in visual outcomes or retinal detachment rates 5
- HSV encephalitis in resource-limited settings: Valacyclovir 1000 mg three times daily achieved adequate CSF acyclovir concentrations 6
- Pediatric patients with difficult IV access: High-dose oral valacyclovir (2g three times daily in adults) may have a role when IV access is problematic 3
However, these are exceptions based on practical considerations, not standard practice.
Common Pitfall to Avoid
Do not attempt to order "Valtrex IV" or "valacyclovir IV"—this formulation does not exist. If your patient requires intravenous antiviral therapy for herpes virus infection, the correct order is acyclovir IV, typically dosed at 5-10 mg/kg every 8 hours depending on the indication 2, 4.
For patients transitioning from IV to oral therapy (such as after initial control of severe HSV lesions), you can switch from IV acyclovir to oral valacyclovir once lesions begin to regress 2.